Publication | Open Access

The histone deacetylase inhibitor trichostatin A sensitizes estrogen receptor α-negative breast cancer cells to tamoxifen

Tumor BiologyBreast OncologyHistone Deacetylase InhibitorEpigenetic RegulationMedicineHormonal ReceptorPharmacologyCancer Cell BiologyBreast CancerAromataseOncologyRadiation OncologyCancer ResearchEndocrine-related Cancer